Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-08-21 Purchase | 2020-08-24 4:31 pm | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 30,000 | $0.69 | $20,700 | 53,251 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-06 Option Award | 2024-09-10 5:00 pm | N/A 2034-09-06 | Vistagen Therapeutics Inc. | VTGN | SAXE JON S Director | 14,100 | $0 | 14,100 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 6:00 pm | N/A 2034-03-04 | Vistagen Therapeutics Inc. | VTGN | SAXE JON S Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:12 pm | N/A 2032-03-01 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-03-19 Exercise | 2021-03-22 7:03 pm | 2018-08-29 2021-04-26 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 2,500 | $0 | 55,751 (Direct) | View |
| 2021-03-19 Exercise | 2021-03-22 7:03 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 2,500 | $1.5 | 55,751 (Direct) | View |
| 2020-12-30 Option Award | 2021-01-04 4:54 pm | N/A 2030-12-30 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-06-17 Option Award | 2020-06-18 9:38 pm | 2021-06-16 2030-06-17 | DURECT CORP | DRRX | SAXE JON S Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 75,000 | $0 | 75,000 (Direct) | View |